Prevention of colorectal cancer by aspirin and/or calcium: Efficacy, mechanisms, and cost effectiveness

Current Colorectal Cancer Reports

Volumn 8, Issue 1, 2012, Pages 51-56

  Pence, Barbara C ^a   Belasco, Eric J ^b   Lyford, Conrad P ^c  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b MONTANA STATE UNIVERSITY   (United States)

^c TEXAS TECH UNIVERSITY   (United States)

Author keywords

Aspirin; Calcium; Calcium sensing receptor; Chemoprevention; Colonoscopy; Colorectal cancer; Cost effectiveness; COX 2; Markov simulation

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM; CYCLOOXYGENASE 2; VITAMIN D;

ARTICLE; CANCER PREVENTION; CHEMOPROPHYLAXIS; COLONOSCOPY; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG MECHANISM; HUMAN; LOW DRUG DOSE; RISK REDUCTION; SUPPLEMENTATION;

EID: 84862766504     PISSN: 15563790     EISSN: 15563804     Source Type: Journal    
DOI: 10.1007/s11888-011-0115-0     Document Type: Article

References (22)

1. Pence BC, Buddingh F. Inhibition of dietary fat-promoted colon carcinogenesis in rats by supplemental calcium or vitamin D3. Carcinogenesis. 1988;9:1887-90.
2. Carroll C, Cooper K, Papioannou D, et al. Supplemental calcium in the chemoprevention of colorectal cancer: a systematic review and meta-analysis. Clin Ther. 2010;32:789-803.
3. Baron JA, Cole BF, Sandler RS, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med. 2003;348:891-9. (Pubitemid 36297997)
4. Dube C, Rostom A, Lewin G, et al. The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med. 2007;146:365-75. (Pubitemid 351650597)
5. Rothwell PM, Wilson M, Elwin C-E, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomized trials. Lancet. 2010;376:1741-50.
6. Benamouzig R, Uzzan B, Deyra J, et al. Prevention by aspirin of colorectal adenoma recurrence: some advances and latest results of the APACC Trial. Curr Colorectal Cancer Rep. 2011;7:33-41.
7. Burn J, Bishop DT, Chapman RD, et al. A randomized placebo-controlled prevention trial of aspirin and/or resistant starch in young people with familial adenomatous polyposis. Cancer Prev Res. 2011;4:655-65.
8. Chan AT. Aspirin and familial adenomatous polyposis: coming full circle. Cancer Prev Res. 2011;4:623-7.
9. Din FVN, Theodoratou E, Farrington SM, et al. Effect of aspirin and NSAIDS on risk and survival from colorectal cancer. Gut. 2010;59:1670-9.
10. Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. N Engl J Med. 1999;340:101-7. (Pubitemid 29054844)
11. Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006;354:684-96. (Pubitemid 43247139)
12. Grau MV, Baron JA, Barry EL, et al. Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2005;14:2353-8. (Pubitemid 41437836)
13. Dupont AW, Arguedas MR, Wilcox CM. Aspirin chemoprevention in patients with increased risk for colorectal cancer: a cost-effectiveness analysis. Aliment Pharmacol Ther. 2007;26:431-41. (Pubitemid 47063144)
14. Hassan C, Rex DK, Cooper GS, et al. Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis. Gut. 2011; doi: 10.1136/gutjnl-2011-300206.
15. Squires H, Tappenden P, Cooper K, et al. Cost-effectiveness of aspirin, celecoxib, and calcium chemoprevention for colorectal cancer. Clin Ther. 2011;33:1289-305.
16. Shaukat A, Parekc M, Lipscomb J, et al. Can calcium chemoprevention of adenoma recurrence substitute or serve as an adjunct for colonoscopic surveillance? Int J Technol Assess Health Care. 2009;25:222-31.
17. Kraus S, Arber N. Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention. Curr Colorectal Cancer Rep. 2011;7:5-7.
18. Chan AT, Ogino S, Fuchs CS. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Eng J Med. 2007;356:2131-42. (Pubitemid 47010839)
19. Ahearn TU, McCollough ML, Flanders WD, et al. A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on markers of their metabolism in normal mucosa of colorectal adenoma patients. Cancer Res. 2011;71:413-23.
20. Peterlik M, Grant WB, Cross HS. Calcium, vitamin D and cancer. Anticancer Res. 2009;29:3687-98.
21. Whitfield JF. The calcium-sensing receptor-a driver of colon cell differentiation. Curr Pharm Biotechnol. 2009;10:311-6.
22. Ghevariya V, Anand S. A short primer on the calcium sensing receptor: an important cog in the colon cancer wheel? Dig Dis Sci. 2011;56:279-84.